Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate.
Department of Dermatology and Venereology, Dayanand Medical and Hospital, Ludhiana, India.
Sukhjot
S
Kaur
Amanjot Kaur
AK
Arora
Jagdev S
JS
Sekhon
Neena
N
Sood
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011565:Psoriasis / Q000139:chemically induced* / Q000175:diagnosis*; D011743:Pyrimidines / Q000009:adverse effects*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C498826:nilotinib; D008727:Methotrexate